Gooreind Pharma
ActiveSummary
Gooreind Pharma has been active since 2004 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €390,026 and a net result of €59,344. Equity remains stable across the filed financial years (±2% per year). Its solvency ranks better than 63% of 12,724 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- Gooreind Pharma
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaams Gewest, Theo Verellenlaan 70,2990 Wuustwezel” (deed in Dutch)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Bepaalde of onbepaalde termijn, één of meer bestuurders” (deed in Dutch)“Vergoeding kosten onverminderd, niet bezoldigd” (deed in Dutch)
- Power of attorneyA special mandate allowing someone to perform one or more acts on the company's behalf.
- One provision in the deed